WallStreetZenWallStreetZen

NYSEMKT: CHRO
Channel Therapeutics Corp Stock Ownership - Who owns Channel Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Channel Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-133,500$0.97
$3.40kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-121,700$0.97
$1.65kBuy
Richard MalamutDirector2024-09-1210,400$0.95
$9.83kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-115,500$0.94
$5.17kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-106,500$0.89
$5.79kBuy

1 of 1

CHRO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRO insiders and whales buy or sell their stock.

CHRO Shareholders

What type of owners hold Channel Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ezra M. Friedberg17.47%1,066,440$1.37MInsider
Knuettel Francis Ii11.12%678,663$868.69kInsider
Motif Pharmaceuticals Ltd7.71%470,674$602.46kInsider
Boswell Prayer Ltd7.53%459,895$588.67kInsider
Aperture Healthcare Ventures Ltd6.99%426,566$546.00kInsider
Ame Equities LLC5.75%351,163$449.49kInsider
Richard Malamut1.50%91,565$117.20kInsider
Todd C. Davis0.48%29,167$37.33kInsider
Two Sigma Securities LLC0.24%14,347$18.36kInstitution
Wealth Enhancement Advisory Services LLC0.17%10,400$13.31kInstitution

1 of 2

CHRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRO0.41%58.56%Net Buying
QNRX7.51%7.08%Net Buying
GNPX1.21%21.13%Net SellingNet Selling
APLM1.16%0.00%
INDP4.42%50.94%Net Buying
View Top Biotech Stocks

Channel Therapeutics Stock Ownership FAQ

Who owns Channel Therapeutics?

Channel Therapeutics (NYSEMKT: CHRO) is owned by 0.41% institutional shareholders, 58.56% Channel Therapeutics insiders, and 41.03% retail investors. Ezra M. Friedberg is the largest individual Channel Therapeutics shareholder, owning 1.07M shares representing 17.47% of the company. Ezra M. Friedberg's Channel Therapeutics shares are currently valued at $1.22M.

If you're new to stock investing, here's how to buy Channel Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.